Wound Care Deal Stagnation or Stabilization? 10 Reasons the Big 10 Stopped Buying (And Who’s Moving Instead)
The global wound care medtech/biomed market from 2H 2024 through today (early 2026) is a study in a unique paradox. […]
Innovation
Mölnlycke’s Lead Role in Siren’s $9.5M Round: A Strategic Shift
(8 Jan 2025) Siren has closed a $9.5M funding round, led by Mölnlycke Health Care (who invested $8M in the
Mölnlycke’s Lead Role in Siren’s $9.5M Round: A Strategic Shift Read Post »
The MedTech Moment: Wound Care Expert Insights
Earlier this week, Diligence Wound Care Global’s Managing Director Rafael Mazuz visited Morgan Stanley’s Global HQ in NYC to spend
The MedTech Moment: Wound Care Expert Insights Read Post »
Upcoming Wound Care Conferences & Events
Upcoming Wound Care and Related Conferences, Meetings, Exhibitions, & Industry Events There used to be a couple of solid online
Upcoming Wound Care Conferences & Events Read Post »
Coloplast’s acquisition of Kerecis: Considerations and implications
Coloplast’s announcement is the latest large and significant advanced wound care (AWC) industry deal. As the high level details have
Coloplast’s acquisition of Kerecis: Considerations and implications Read Post »
Net Health Acquires Tissue Analytics
Today (14 May 2020), Net Health, a leading specialty health software firm with particularly successful market penetration in US wound
Net Health Acquires Tissue Analytics Read Post »
Followup Q&A to April 2020 Business of US Wound Care for Executives eLive Event [Video]
For those of you who joined our recent (April 2020) eLive interactive events on The Business of US Wound Care
Followup Q&A to April 2020 Business of US Wound Care for Executives eLive Event [Video] Read Post »
COVID-19: Preliminary Operational and Commercial Wound Care Insights
Advanced wound care’s position in the evolving COVID-19 landscape Global economies have been slammed by COVID-19 in the first part
COVID-19: Preliminary Operational and Commercial Wound Care Insights Read Post »
Underappreciated Advanced Wound Care Opportunities in 2020 and Beyond
Despite the overwhelming majority of R&D, regulatory, sales, marketing, and corporate finance focus in the advanced wound care (AWC) sector
Underappreciated Advanced Wound Care Opportunities in 2020 and Beyond Read Post »
EWMA 2019 and Executive Industry Forum: Unlocking the Commercial Potential of the US & Asia
The European Wound Management Association (EWMA) conference in Gothenburg, Sweden earlier this month was a great success. We witnessed several
Consolidation, M&A Integrations as a Competitive Advantage, and Other Advanced Wound Care Industry Insights from 1H 2019 and SAWC Spring [Video]
At the recent Symposium on Advanced Wound Care (SAWC Spring 2019), there were several interesting developments and companies to watch
Perspectives on Smith & Nephew’s Announced Acquisition of Osiris Therapeutics Today
What happened? Smith & Nephew (NYSE: SNN) will be acquiring Osiris Therapeutics (NASDAQ: OSIR) for $660M. The investment, announced today,
Perspectives on Smith & Nephew’s Announced Acquisition of Osiris Therapeutics Today Read Post »
Confused by Recent Wound Care Digital Health Developments and Their Implications?
In many ways, the pace of innovation in advanced wound care can feel slow compared to other areas of medtech.
Confused by Recent Wound Care Digital Health Developments and Their Implications? Read Post »
Diligence Wound Care Global Managing Director Rafael Mazuz Joins Tissue Analytics Board as Independent Director
We’re thrilled to share this important announcement (read the official press release here). But even before getting into the details of
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business Outlook
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business